Inovio Pharmaceuticals, Inc.
INO· Nasdaq
INOInovio Pharmaceuticals, Inc.
Filed Mar 17, 2014 · 10-K · 76 days after period end · 0001055726-14-000003
| Metric | Q4 2013 | Q4 2012 | Q4 2011 | Q4 2010dderived from reported figures |
|---|---|---|---|---|
| Revenue | $1.74M | $1.13M | $1.63M | — |
| Net Income | -$15.45M | -$658.75K | -$5.48M | — |
| EPS Diluted | -$0.30 | $0.00 | -$0.04 | — |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Inovio Pharmaceuticals, Inc. · CIK 1055726 · Engraved from SEC EDGAR
ended Dec 31, 2013 · filed Mar 17, 2014 · 76 d after period end
